IGHE and infection: In this community-based, intervention study, we present data that suggest the association of ShTAL1-IgE responses with a reduced risk to re-infection 7 weeks after PZQ treatment (Follow-up), as has been similarly shown for a cohort of Gabonese schoolchildren [25], and for IgE responses to its orthologous Schistosoma mansoni antigen, SmTAL1.